Published in Nat Genet on November 01, 1992
Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci U S A (1993) 1.97
Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet (1995) 1.91
The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res (2008) 1.46
CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics (2007) 1.36
Codon reiteration and the evolution of proteins. Proc Natl Acad Sci U S A (1994) 1.29
Length variation of CAG/CAA trinucleotide repeats in natural populations of Drosophila melanogaster and its relation to the recombination rate. Genetics (1996) 1.18
Structures of trinucleotide repeats in human transcripts and their functional implications. Nucleic Acids Res (2003) 1.14
Possible role of natural selection in the formation of tandem-repetitive noncoding DNA. Genetics (1994) 1.09
LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats. J Cell Biol (1995) 1.03
Search for unstable DNA in schizophrenia families with evidence for genetic anticipation. Am J Hum Genet (1996) 0.89
The universal trend of amino acid gain-loss is caused by CpG hypermutability. J Mol Evol (2008) 0.88
Amino acid repeats cause extraordinary coding sequence variation in the social amoeba Dictyostelium discoideum. PLoS One (2012) 0.87
The exact numbers of possible microsatellite motifs. Am J Hum Genet (1994) 0.84
Meiotic instability associated with the CAGR1 trinucleotide repeat at 13q13. J Med Genet (1997) 0.80
The gene for Huntington's disease. BMJ (1993) 0.79
Multivariate analysis of factors influencing repeat expansion detection. Genome Res (1998) 0.77
A rapid method for sequencing trinucleotide repeats. Nucleic Acids Res (1993) 0.75
Cloning (CAG/GTC)n STSs by an Alu-(CAG/GTC)n PCR method: an approach to human chromosome 12 and spinocerebellar ataxia 2 (SCA2). Nucleic Acids Res (1996) 0.75
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
Report of the Committee on the Genetic Constitution of Chromosomes 1 and 2. Cytogenet Cell Genet (1985) 7.70
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell (2001) 6.50
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene (1998) 4.88
FMR1 protein: conserved RNP family domains and selective RNA binding. Science (1993) 4.77
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. Genomics (1990) 4.34
Fragile X genotype characterized by an unstable region of DNA. Science (1991) 4.33
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med (2001) 3.84
Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet (2001) 3.82
FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell (1997) 3.71
Trinucleotide repeat expansion and human disease. Annu Rev Genet (1995) 3.47
A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J (2001) 3.42
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats. Nat Genet (1997) 3.30
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A (1998) 3.26
The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res (2001) 3.18
The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet (1984) 3.17
Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nat Genet (1996) 3.13
Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod (2004) 3.01
Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci (1997) 2.93
Population-based study of congenital heart defects in Down syndrome. Am J Med Genet (1998) 2.74
Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell (1994) 2.73
Translational suppression by trinucleotide repeat expansion at FMR1. Science (1995) 2.73
Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet (1993) 2.69
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet (1999) 2.59
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet (1996) 2.49
Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J (1997) 2.29
Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry (1998) 2.18
Report of the committee on the genetic constitution of chromosome 1. Cytogenet Cell Genet (1989) 2.18
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet (2000) 2.17
Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. J Biol Chem (1997) 2.14
The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites. Science (1987) 2.13
Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol Cell Biol (1999) 2.13
Understanding the molecular basis of fragile X syndrome. Hum Mol Genet (2000) 2.13
In vivo disassembly of free polyubiquitin chains by yeast Ubp14 modulates rates of protein degradation by the proteasome. EMBO J (1997) 2.03
Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J Biol Chem (1980) 1.99
TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res (2000) 1.98
Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet (1993) 1.95
Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet (1995) 1.91
Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience (1999) 1.91
Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet (1998) 1.75
Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet (1997) 1.74
Segregation analysis of balanced pericentric inversions in pedigree data. Clin Genet (1986) 1.65
A suggestion for naming faces of ring compounds. Proc Natl Acad Sci U S A (1980) 1.64
Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem (1998) 1.63
Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc Natl Acad Sci U S A (1981) 1.62
Effect of meiotic recombination on the production of aneuploid gametes in humans. Cytogenet Genome Res (2005) 1.61
Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry (1996) 1.61
Three-dimensional structure of ubiquitin at 2.8 A resolution. Proc Natl Acad Sci U S A (1985) 1.60
Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet (2000) 1.57
Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21. Hum Mol Genet (1997) 1.57
Familial transmission of the FMR1 CGG repeat. Am J Hum Genet (1996) 1.53
Comparison of the three-dimensional structures of human, yeast, and oat ubiquitin. J Biol Chem (1987) 1.52
Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol (1990) 1.51
Report of the committee on linkage and gene order. Cytogenet Cell Genet (1990) 1.48
XY chromosome nondisjunction in man is associated with diminished recombination in the pseudoautosomal region. Am J Hum Genet (1991) 1.47
Detection, resolution, and nomenclature of multiple ubiquitin carboxyl-terminal esterases from bovine calf thymus. Biochemistry (1989) 1.43
Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod (2007) 1.42
High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet (1993) 1.42
Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet (1999) 1.41
Guidelines for human linkage maps: an international system for human linkage maps (ISLM, 1990). Genomics (1991) 1.37
Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet (2010) 1.33
Stimulation of ATP-dependent proteolysis requires ubiquitin with the COOH-terminal sequence Arg-Gly-Gly. J Biol Chem (1981) 1.32
Physical map of human Xq27-qter: localizing the region of the fragile X mutation. Proc Natl Acad Sci U S A (1991) 1.28
Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am J Hum Genet (1996) 1.28
Non-disjunction in human sperm: evidence for an effect of increasing paternal age. Hum Mol Genet (1995) 1.26
Guidelines for human linkage maps. An International System for Human Linkage Maps (ISLM, 1990). Ann Hum Genet (1991) 1.25
Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet (2009) 1.25
Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome. Am J Hum Genet (2000) 1.25
Methodology employed for anaerobic spectrophotometric titrations and for computer-assisted data analysis. Methods Enzymol (1979) 1.25
Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet (1996) 1.23
An -N-acetyl-D-glycosamine binding lectin from Bandeiraea simplicifolia seeds. Arch Biochem Biophys (1976) 1.22
Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1. Hum Mol Genet (1998) 1.18
Association of the mouse infertility factor DAZL1 with actively translating polyribosomes. Biol Reprod (2000) 1.18
Fanconi anemia: evidence for linkage heterogeneity on chromosome 20q. Genomics (1991) 1.18
A revised map of chromosome 1. Ann Hum Genet (1984) 1.16
Paternal nondisjunction in trisomy 21: excess of male patients. Hum Mol Genet (1993) 1.15
Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor. J Biol Chem (2000) 1.13
Distribution of lod scores under uncertain mode of inheritance. Am J Hum Genet (1993) 1.12
Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. Am J Med Genet (1992) 1.12
Alcohol-induced conformational changes of ubiquitin. Arch Biochem Biophys (1986) 1.11
Examination of factors associated with instability of the FMR1 CGG repeat. Am J Hum Genet (1998) 1.11
FMR1 in global populations. Am J Hum Genet (1996) 1.11
Further localization of X-linked hydrocephalus in the chromosomal region Xq28. Am J Hum Genet (1992) 1.11
Actin-binding protein (ABP-280) filamin gene (FLN) maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. Genomics (1993) 1.10
Molecular evidence for true isochromosome 21q. Hum Genet (1988) 1.10
Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation. Biochemistry (2000) 1.09